J INTERN MED: COVID-19 Survivors Short-Term Neuropsychotic Outcomes and Quality of Life

The clinical effects of COVID-19 are getting more and more attention.
, however, its effects on neurocognitive, mental health and quality of life (QoL) in post-acute post-stage survivors are not yet clear.
, researchers evaluated neurocognitive function, mental symptoms, and quality of life in COVID-19 survivors shortly after they were discharged from the hospital, according to a recent study published in Journal of Internal Medicine, an authoritative journal in the field of internal medicine.
this was a cross-sectional analysis of a prospective study of COVID-19 survivors who were followed up for 2 months after discharge from the hospital.
used a series of standardized tools to assess the subjects' neurocognitive function, incidence of mental illness, and quality of life (mental and physical components) in telephone interviews.
179 of the 229 screened patients were included in the final analysis.
Among survivors, the prevalence of moderate impairment of instant language memory and learning was 38%, delayed language memory (11.8%), language fluency (34.6%) and working memory (execution function, 6.1%).
addition, 58.7 percent of patients had at least one functional neurocognitive disorder.
screening rates for anxiety, depression and post-traumatic stress disorder were 29.6 per cent, 26.8 per cent and 25.1 per cent, respectively.
addition, 39.1% of patients had mental illness.
44.1 per cent and 39.1 per cent, respectively, had a lower physical and mental quality of life.
and mental illness are associated with neurocognitive disorders, and women are associated with the incidence of mental illness.
, coVID-19 survivors in hospital showed fairly common neurocognitive disorders, morbidity of mental illness, and poor quality of life in the short term.
has not yet determined whether these effects will persist in the long term.